Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/1997
10/07/1997US5674492 Method of preventing or treating disease characterized by neoplastic cells expressing CD40
10/07/1997US5674484 Vaccine antigens for treatment of poultry
10/07/1997CA1339489C Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
10/02/1997WO1997035991A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997WO1997035978A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997WO1997035976A2 Epidermal differentiation factor
10/02/1997WO1997035971A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
10/02/1997WO1997035962A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator
10/02/1997WO1997035885A1 ErbB3 ANTIBODIES
10/02/1997WO1997035872A1 CASPR/p190, A FUNCTIONAL LIGAND FOR RPTP-BETA AND THE AXONAL CELL RECOGNITION MOLECULE CONTACTIN
10/02/1997WO1997035870A1 Growth factor htter36
10/02/1997WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997WO1997035614A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997WO1997035612A1 Functional fragment antigen of tetanus toxin and tetanus vaccine
10/02/1997WO1997035610A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997WO1997035600A1 Glycosylated amylins
10/02/1997WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/02/1997CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997CA2250452A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997CA2250207A1 A novel mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes
10/02/1997CA2250166A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997CA2250034A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997CA2249998A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997CA2249254A1 Epidermal differentiation factor
10/02/1997CA2248318A1 Growth factor htter36
10/01/1997EP0798384A1 Biotechnological method of producing biotin
10/01/1997EP0798378A2 Estrogen receptor
10/01/1997EP0798376A1 Novel keratan sulfate hydrolase
10/01/1997EP0797675A1 Reversible nuclear genetic system for male sterility in transgenic plants
10/01/1997EP0797667A1 Papillomavirus vaccine
10/01/1997EP0797666A2 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase
10/01/1997EP0797665A1 A kinase anchoring protein and uses thereof
10/01/1997EP0797664A1 Human interleukin-11 receptor
10/01/1997EP0797663A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage
10/01/1997EP0797661A1 Human mu opioid receptor
10/01/1997EP0797592A1 Human stanniocalcin-alpha
10/01/1997EP0797591A1 A novel chemokine expressed in inflamed adenoid, its production and uses
10/01/1997EP0797588A1 BETA 3? INTEGRIN SUBUNIT SPECIFIC POLYPEPTIDES, cDNAs WHICH ENCODE THESE POLYPEPTIDES AND METHODS OF PRODUCING THESE POLYPEPTIDES
10/01/1997EP0797587A1 Recombinant antigen for diagnosing rheumatoid arthritis
10/01/1997EP0797586A1 NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI
10/01/1997EP0797585A1 Helicobacter lactoferrin receptor
10/01/1997EP0797581A1 Novel protein tyrosine kinase, jak3
10/01/1997EP0797452A1 Modulating the immune response
10/01/1997EP0698104B1 Hippuricase gene
10/01/1997EP0694075A4 Thermostable dna topoisomerase v
10/01/1997EP0673440A4 Mammalian muscle nad:arginine adp-ribosyltransferase.
10/01/1997EP0574402B1 Expression of pace in host cells and methods of use thereof
10/01/1997EP0396699B1 A genetic construct of which protein-coding dna comprises introns and is designed for protein production in transgenic animals
10/01/1997CN1160721A Fibrillating cell growth factor-2 analogue and its production method and use
10/01/1997CA2201185A1 Anti-fas recombinant antibodies and dna therefor
09/1997
09/30/1997US5672691 Recombinant core streptavidin
09/30/1997US5672687 Medical diagnosis; bone marrow transplants
09/30/1997US5672686 Genetic engineering
09/30/1997US5672684 Polypeptide having sequence of vp7 protein of human rotavirus serotype 4
09/30/1997US5672513 Carcino-embryonic antigen derivatives lacking the carboxyl terminal end
09/30/1997US5672500 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
09/30/1997US5672489 Catalytic antibodies hydrolyzing acylated carbohydrates in a regioselective and stereoselective manner
09/30/1997US5672487 Transformation yeast with an expression cassette polypeptide sequence comprising a leader of a neurohormone, an adaptor producing an alpha-helix structure, a processing signal and a structural gene
09/30/1997US5672486 Protein polyligands joined to a stable protein core
09/30/1997US5672485 Immortalized cell lines for virus growth
09/30/1997US5672372 Method for sweetening a food composition with single-chain monellin analogs
09/25/1997WO1997035204A1 Method for predicting the outcome of hepatitis b infection
09/25/1997WO1997035037A1 Tissue remodeling proteins
09/25/1997WO1997035019A1 Protein tyrosine phosphatases of hematopoietic cells
09/25/1997WO1997035015A2 Tyrosine-phosphatase-related protein
09/25/1997WO1997035014A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a)
09/25/1997WO1997035011A1 Recombinant process for the production in pseudomonas putida of the cytochrome c551 of pseudomonas aeruginosa
09/25/1997WO1997035010A1 Chemokine alpha 2
09/25/1997WO1997035009A1 Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
09/25/1997WO1997035007A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use
09/25/1997WO1997035006A1 Human cell death-associated protein
09/25/1997WO1997034931A1 Antibody specific for staphylococcus aureus, and use thereof
09/25/1997WO1997034927A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
09/25/1997WO1997034912A1 Directed switch-mediated dna recombination
09/25/1997WO1997034911A1 Apoptosis inducing molecule ii
09/25/1997WO1997034636A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
09/25/1997WO1997034632A1 Glycosylated humanized b-cell specific antibodies
09/25/1997WO1997034631A1 Immunoglobin-like domains with increased half lives
09/25/1997WO1997030082A3 Antifungic and antibacterial peptide
09/25/1997WO1997019113A3 Monoclonal antiidiotypic antibodies (ab2) and uses thereof
09/25/1997DE19634159C1 Hybrid cells prepared by fusing malignant B cells with hybridoma that expresses antibodies
09/25/1997CA2250076A1 Method for predicting the outcome of hepatitis b infection
09/25/1997CA2249997A1 Chemokine alpha 2
09/25/1997CA2249551A1 A kinase capable of site-specific phosphorylation of i.kappa.b.alpha.
09/25/1997CA2249195A1 Immunoglobin-like domains with increased half lives
09/25/1997CA2249179A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use
09/25/1997CA2248868A1 Apoptosis inducing molecule ii
09/25/1997CA2248614A1 Human cell death-associated protein
09/25/1997CA2242342A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
09/25/1997CA2221591A1 Tissue remodeling proteins
09/24/1997EP0796913A2 GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins
09/24/1997EP0796335A1 Production of peptides using recombinant fusion protein constructs
09/24/1997EP0796332A1 Neisseria meningitidis subunit tbp2
09/24/1997EP0796331A2 Production and administration of high titer recombinant retroviruses
09/24/1997EP0796330A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
09/24/1997EP0796326A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease